PMC:7228307 / 60893-61044 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1239","span":{"begin":85,"end":103},"obj":"Disease"}],"attributes":[{"id":"A1239","pred":"tao:has_database_id","subj":"1239","obj":"MESH:D003141"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T113","span":{"begin":85,"end":103},"obj":"Disease"}],"attributes":[{"id":"A113","pred":"mondo_id","subj":"T113","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T98304","span":{"begin":68,"end":81},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A43016","pred":"meddra_id","subj":"T98304","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062026"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T256","span":{"begin":85,"end":103},"obj":"http://purl.obolibrary.org/obo/IDO_0000436"},{"id":"T257","span":{"begin":96,"end":103},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}

{"project":"LitCovid-sample-Enju","denotations":[{"id":"T540","span":{"begin":0,"end":10},"obj":"NNS"},{"id":"T541","span":{"begin":11,"end":21},"obj":"VBG"},{"id":"T542","span":{"begin":22,"end":30},"obj":"JJ"},{"id":"T543","span":{"begin":31,"end":35},"obj":"NNS"},{"id":"T544","span":{"begin":36,"end":39},"obj":"CC"},{"id":"T545","span":{"begin":40,"end":46},"obj":"JJ"},{"id":"T546","span":{"begin":47,"end":57},"obj":"NNS"},{"id":"T547","span":{"begin":58,"end":61},"obj":"VBP"},{"id":"T548","span":{"begin":62,"end":67},"obj":"IN"},{"id":"T549","span":{"begin":68,"end":81},"obj":"NN"},{"id":"T550","span":{"begin":82,"end":84},"obj":"IN"},{"id":"T551","span":{"begin":85,"end":95},"obj":"JJ"},{"id":"T552","span":{"begin":96,"end":103},"obj":"NN"},{"id":"T553","span":{"begin":104,"end":107},"obj":"IN"},{"id":"T554","span":{"begin":108,"end":122},"obj":"NN"},{"id":"T555","span":{"begin":123,"end":131},"obj":"NN"},{"id":"T556","span":{"begin":132,"end":134},"obj":"IN"},{"id":"T557","span":{"begin":135,"end":142},"obj":"JJ"},{"id":"T558","span":{"begin":143,"end":150},"obj":"NNS"}],"relations":[{"id":"R554","pred":"arg1Of","subj":"T540","obj":"T541"},{"id":"R555","pred":"arg2Of","subj":"T544","obj":"T541"},{"id":"R556","pred":"arg1Of","subj":"T543","obj":"T542"},{"id":"R557","pred":"arg1Of","subj":"T543","obj":"T544"},{"id":"R558","pred":"arg2Of","subj":"T546","obj":"T544"},{"id":"R559","pred":"arg1Of","subj":"T546","obj":"T545"},{"id":"R560","pred":"arg1Of","subj":"T540","obj":"T547"},{"id":"R561","pred":"arg2Of","subj":"T548","obj":"T547"},{"id":"R562","pred":"arg1Of","subj":"T540","obj":"T548"},{"id":"R563","pred":"arg2Of","subj":"T549","obj":"T548"},{"id":"R564","pred":"arg1Of","subj":"T547","obj":"T550"},{"id":"R565","pred":"arg2Of","subj":"T552","obj":"T550"},{"id":"R566","pred":"arg1Of","subj":"T552","obj":"T551"},{"id":"R567","pred":"arg1Of","subj":"T552","obj":"T553"},{"id":"R568","pred":"arg2Of","subj":"T555","obj":"T553"},{"id":"R569","pred":"arg1Of","subj":"T555","obj":"T554"},{"id":"R570","pred":"arg1Of","subj":"T555","obj":"T556"},{"id":"R571","pred":"arg2Of","subj":"T558","obj":"T556"},{"id":"R572","pred":"arg1Of","subj":"T558","obj":"T557"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"1239","span":{"begin":85,"end":103},"obj":"Disease"}],"attributes":[{"id":"A1239","pred":"pubann:denotes","subj":"1239","obj":"MESH:D003141"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T336","span":{"begin":0,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T50","span":{"begin":85,"end":103},"obj":"Disease"}],"attributes":[{"id":"A50","pred":"mondo_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}

{"project":"LitCovid-sentences","denotations":[{"id":"T336","span":{"begin":0,"end":151},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatments comprising multiple mAbs and immune stimulants are under investigation in infectious disease for neutralization coverage of variant strains."}